BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31080095)

  • 1. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.
    Taylor SA; Mallett S; Beare S; Bhatnagar G; Blunt D; Boavida P; Bridgewater J; Clarke CS; Duggan M; Ellis S; Glynne-Jones R; Goh V; Groves AM; Hameeduddin A; Janes SM; Johnston EW; Koh DM; Miles A; Morris S; Morton A; Navani N; O'Donohue J; Oliver A; Padhani AR; Pardoe H; Patel U; Punwani S; Quinn L; Rafiee H; Reczko K; Rockall AG; Shahabuddin K; Sidhu HS; Teague J; Thaha MA; Train M; van Ree K; Wijeyekoon S; Halligan S;
    Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):529-537. PubMed ID: 31080095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.
    Taylor SA; Mallett S; Ball S; Beare S; Bhatnagar G; Bhowmik A; Boavida P; Bridgewater J; Clarke CS; Duggan M; Ellis S; Glynne-Jones R; Goh V; Groves AM; Hameeduddin A; Janes SM; Johnston EW; Koh DM; Lock S; Miles A; Morris S; Morton A; Navani N; Oliver A; O'Shaughnessy T; Padhani AR; Prezzi D; Punwani S; Quinn L; Rafiee H; Reczko K; Rockall AG; Russell P; Sidhu HS; Strickland N; Tarver K; Teague J; Halligan S;
    Lancet Respir Med; 2019 Jun; 7(6):523-532. PubMed ID: 31080129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies.
    Taylor SA; Mallett S; Miles A; Morris S; Quinn L; Clarke CS; Beare S; Bridgewater J; Goh V; Janes S; Koh DM; Morton A; Navani N; Oliver A; Padhani A; Punwani S; Rockall A; Halligan S
    Health Technol Assess; 2019 Dec; 23(66):1-270. PubMed ID: 31855148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).
    Taylor SA; Mallett S; Miles A; Beare S; Bhatnagar G; Bridgewater J; Glynne-Jones R; Goh V; Groves AM; Janes SM; Koh DM; Morris S; Morton A; Navani N; Oliver A; Padhani AR; Punwani S; Rockall AG; Halligan S
    BMC Cancer; 2017 May; 17(1):299. PubMed ID: 28464835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment.
    Miles A; Taylor SA; Evans REC; Halligan S; Beare S; Bridgewater J; Goh V; Janes S; Navani N; Oliver A; Morton A; Rockall A; Clarke CS; Morris S;
    Eur Radiol; 2019 Jul; 29(7):3889-3900. PubMed ID: 30937589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.
    Adeleke S; Latifoltojar A; Sidhu H; Galazi M; Shah TT; Clemente J; Davda R; Payne HA; Chouhan MD; Lioumi M; Chua S; Freeman A; Rodriguez-Justo M; Coolen A; Vadgama S; Morris S; Cook GJ; Bomanji J; Arya M; Chowdhury S; Wan S; Haroon A; Ng T; Ahmed HU; Punwani S
    BMC Med Imaging; 2019 Nov; 19(1):90. PubMed ID: 31730466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Evaluation of Machine Learning in Whole-Body Magnetic Resonance Imaging for Detecting Metastases in Patients With Lung or Colon Cancer: A Diagnostic Test Accuracy Study.
    Rockall AG; Li X; Johnson N; Lavdas I; Santhakumaran S; Prevost AT; Punwani S; Goh V; Barwick TD; Bharwani N; Sandhu A; Sidhu H; Plumb A; Burn J; Fagan A; Wengert GJ; Koh DM; Reczko K; Dou Q; Warwick J; Liu X; Messiou C; Tunariu N; Boavida P; Soneji N; Johnston EW; Kelly-Morland C; De Paepe KN; Sokhi H; Wallitt K; Lakhani A; Russell J; Salib M; Vinnicombe S; Haq A; Aboagye EO; Taylor S; Glocker B
    Invest Radiol; 2023 Dec; 58(12):823-831. PubMed ID: 37358356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study.
    Evans R; Taylor S; Janes S; Halligan S; Morton A; Navani N; Oliver A; Rockall A; Teague J; Miles A;
    BMJ Open; 2017 Sep; 7(9):e016391. PubMed ID: 28882915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.
    Miles A; Evans RE; Halligan S; Beare S; Bridgewater J; Goh V; Janes SM; Navani N; Oliver A; Morton A; Morris S; Rockall A; Taylor SA;
    J Med Imaging Radiat Oncol; 2020 Aug; 64(4):537-545. PubMed ID: 32410378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
    Johnston EW; Latifoltojar A; Sidhu HS; Ramachandran N; Sokolska M; Bainbridge A; Moore C; Ahmed HU; Punwani S
    Eur Radiol; 2019 Jun; 29(6):3159-3169. PubMed ID: 30519933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including
    Latifoltojar A; Punwani S; Lopes A; Humphries PD; Klusmann M; Menezes LJ; Daw S; Shankar A; Neriman D; Fitzke H; Clifton-Hadley L; Smith P; Taylor SA
    Eur Radiol; 2019 Jan; 29(1):202-212. PubMed ID: 29948084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study.
    Spijkers S; Littooij AS; Kwee TC; Tolboom N; Beishuizen A; Bruin MCA; Elias SG; van de Brug T; Enríquez G; Sábado C; Miller E; Granata C; de Lange C; Verzegnassi F; Greer MC; de Keizer B; Nievelstein RAJ
    Eur Radiol; 2021 Mar; 31(3):1494-1504. PubMed ID: 32880696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations.
    Evans RE; Taylor SA; Beare S; Halligan S; Morton A; Oliver A; Rockall A; Miles A
    Br J Radiol; 2018 Jun; 91(1086):20170731. PubMed ID: 29528257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.
    Schmidt GP; Baur-Melnyk A; Haug A; Utzschneider S; Becker CR; Tiling R; Reiser MF; Hermann KA
    Eur Radiol; 2009 Jun; 19(6):1366-78. PubMed ID: 19190917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of contrast-enhanced CT, dual-layer detector spectral CT, and whole-body MRI in suspected metastatic breast cancer: a prospective diagnostic accuracy study.
    Buus TW; Rasmussen F; Nellemann HM; Løgager V; Jensen AB; Hauerslev KR; Christiansen P; Pedersen EM
    Eur Radiol; 2021 Dec; 31(12):8838-8849. PubMed ID: 34008104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of whole-body MRI including diffusion-weighted sequences in the initial staging of breast cancer patients at high risk of metastases in comparison with PET-CT: a prospective cohort study.
    Hottat NA; Badr DA; Ben Ghanem M; Besse-Hammer T; Lecomte SM; Vansteelandt C; Lecomte SL; Khaled C; De Grove V; Salem Wehbe G; Cannie MM; Jani JC
    Eur Radiol; 2024 Jan; 34(1):165-178. PubMed ID: 37555959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
    Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
    Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study.
    De Vuysere S; Vandecaveye V; De Bruecker Y; Carton S; Vermeiren K; Tollens T; De Keyzer F; Dresen RC
    BMC Med Imaging; 2021 Feb; 21(1):18. PubMed ID: 33546626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of distant metastases in rectal cancer: contrast-enhanced CT vs whole body MRI.
    Yoon JH; Yu MH; Hur BY; Park CM; Lee JM
    Eur Radiol; 2021 Jan; 31(1):104-111. PubMed ID: 32789755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
    Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.